Novel drug approvals – December 2023

Dec 292023
 

Drug Name Active Ingredient Approval Date FDA-approved use on approval date* Wainua eplontersen 12/21/2023 To treat polyneuropathy of hereditary transthyretin-mediated amyloidosis Filsuvez birch triterpenes 12/18/2023

FDA Drug Safety Information for December 26, 2023

Dec 262023
 

Date Brand Name(s) Description Type Reason Company  26-Dec-2023 Hospira 4.2% Sodium bicarbonate injection, 8.4% Sodium bicarbonate injection, Atropine sulfate injection Drugs Presence of Glass Particulate

FDA Drug Safety Information for December 22, 2023

Dec 222023
 

Date Brand Name(s) Description Type Reason Company  22-Dec-2023 Americaine Benzocaine Topical Anesthetic Spray Drugs Presence of benzene Insight Pharmaceuticals 22-Dec-2023 No Brand Bleomycin for Injection,

FDA Drug Safety Information for December 21, 2023

Dec 212023
 

Date Brand Name(s) Description Type Reason Company  21-Dec-2023 ResMed Masks with magnets Medical Devices Potential for magnetic interference near certain implants and medical devices ResMed

 Older Entries  Newer Entries